Global and China Veterinary Vaccine Market Insights, Forecast to 2027

Global and China Veterinary Vaccine Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Veterinary Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Veterinary Vaccine Market Size Growth Rate by Type
1.2.2 Live Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.2.4 Others
1.3 Market by Application
1.3.1 Global Veterinary Vaccine Market Size Growth Rate by Application
1.3.2 Livestock
1.3.3 Swine
1.3.4 Chicken
1.3.5 Dog & Cat
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Veterinary Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Veterinary Vaccine Revenue 2016-2027
2.1.2 Global Veterinary Vaccine Sales 2016-2027
2.2 Global Veterinary Vaccine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Veterinary Vaccine Historical Market Size by Region (2016-2021)
2.3.1 Global Veterinary Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Veterinary Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Veterinary Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Veterinary Vaccine Sales Forecast by Region (2022-2027)
2.4.2 Global Veterinary Vaccine Revenue Forecast by Region (2022-2027)
3 Global Veterinary Vaccine Competitor Landscape by Players
3.1 Global Top Veterinary Vaccine Manufacturers by Sales
3.1.1 Global Veterinary Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global Veterinary Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Veterinary Vaccine Manufacturers by Revenue
3.2.1 Key Veterinary Vaccine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Veterinary Vaccine Revenue by Manufacturers (2016-2021)
3.2.3 Global Veterinary Vaccine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Veterinary Vaccine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Veterinary Vaccine Revenue in 2020
3.2.6 Global Veterinary Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Veterinary Vaccine Price by Manufacturers
3.4 Global Veterinary Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Veterinary Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Veterinary Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Veterinary Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Veterinary Vaccine Market Size by Type (2016-2021)
4.1.1 Global Veterinary Vaccine Sales by Type (2016-2021)
4.1.2 Global Veterinary Vaccine Revenue by Type (2016-2021)
4.1.3 Veterinary Vaccine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Veterinary Vaccine Market Size Forecast by Type (2022-2027)
4.2.1 Global Veterinary Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Veterinary Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Veterinary Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Veterinary Vaccine Market Size by Application (2016-2021)
5.1.1 Global Veterinary Vaccine Sales by Application (2016-2021)
5.1.2 Global Veterinary Vaccine Revenue by Application (2016-2021)
5.1.3 Veterinary Vaccine Price by Application (2016-2021)
5.2 Veterinary Vaccine Market Size Forecast by Application (2022-2027)
5.2.1 Global Veterinary Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Veterinary Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Veterinary Vaccine Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Veterinary Vaccine Market Size YoY Growth 2016-2027
6.1.1 China Veterinary Vaccine Sales YoY Growth 2016-2027
6.1.2 China Veterinary Vaccine Revenue YoY Growth 2016-2027
6.1.3 China Veterinary Vaccine Market Share in Global Market 2016-2027
6.2 China Veterinary Vaccine Market Size by Players (International and Local Players)
6.2.1 China Top Veterinary Vaccine Players by Sales (2016-2021)
6.2.2 China Top Veterinary Vaccine Players by Revenue (2016-2021)
6.3 China Veterinary Vaccine Historic Market Review by Type (2016-2021)
6.3.1 China Veterinary Vaccine Sales Market Share by Type (2016-2021)
6.3.2 China Veterinary Vaccine Revenue Market Share by Type (2016-2021)
6.3.3 China Veterinary Vaccine Price by Type (2016-2021)
6.4 China Veterinary Vaccine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Veterinary Vaccine Sales Forecast by Type (2022-2027)
6.4.2 China Veterinary Vaccine Revenue Forecast by Type (2022-2027)
6.4.3 China Veterinary Vaccine Price Forecast by Type (2022-2027)
6.5 China Veterinary Vaccine Historic Market Review by Application (2016-2021)
6.5.1 China Veterinary Vaccine Sales Market Share by Application (2016-2021)
6.5.2 China Veterinary Vaccine Revenue Market Share by Application (2016-2021)
6.5.3 China Veterinary Vaccine Price by Application (2016-2021)
6.6 China Veterinary Vaccine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Veterinary Vaccine Sales Forecast by Application (2022-2027)
6.6.2 China Veterinary Vaccine Revenue Forecast by Application (2022-2027)
6.6.3 China Veterinary Vaccine Price Forecast by Application (2022-2027)
7 North America
7.1 North America Veterinary Vaccine Market Size YoY Growth 2016-2027
7.2 North America Veterinary Vaccine Market Facts & Figures by Country
7.2.1 North America Veterinary Vaccine Sales by Country (2016-2021)
7.2.2 North America Veterinary Vaccine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Veterinary Vaccine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Veterinary Vaccine Market Facts & Figures by Region
8.2.1 Asia Pacific Veterinary Vaccine Sales by Region (2016-2021)
8.2.2 Asia Pacific Veterinary Vaccine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Veterinary Vaccine Market Size YoY Growth 2016-2027
9.2 Europe Veterinary Vaccine Market Facts & Figures by Country
9.2.1 Europe Veterinary Vaccine Sales by Country (2016-2021)
9.2.2 Europe Veterinary Vaccine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
9.2.7 Greece
9.2.8 Greece
9.2.9 Ukraine
9.2.10 Moldova
9.2.11 Albania
9.2.12 Serbia
10 Latin America
10.1 Latin America Veterinary Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America Veterinary Vaccine Market Facts & Figures by Country
10.2.1 Latin America Veterinary Vaccine Sales by Country (2016-2021)
10.2.2 Latin America Veterinary Vaccine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Veterinary Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Veterinary Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Veterinary Vaccine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Veterinary Vaccine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
11.2.6 Egypt
11.2.7 South Africa
11.2.8 Israel
11.2.9 Kuwait
11.2.10 Iran
12 Company Profiles
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Description and Business Overview
12.1.3 Merck Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck Veterinary Vaccine Products Offered
12.1.5 Merck Recent Development
12.2 Zoetis
12.2.1 Zoetis Corporation Information
12.2.2 Zoetis Description and Business Overview
12.2.3 Zoetis Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Zoetis Veterinary Vaccine Products Offered
12.2.5 Zoetis Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Corporation Information
12.3.2 Boehringer Ingelheim Description and Business Overview
12.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Boehringer Ingelheim Veterinary Vaccine Products Offered
12.3.5 Boehringer Ingelheim Recent Development
12.4 Ceva
12.4.1 Ceva Corporation Information
12.4.2 Ceva Description and Business Overview
12.4.3 Ceva Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Ceva Veterinary Vaccine Products Offered
12.4.5 Ceva Recent Development
12.5 CAHIC
12.5.1 CAHIC Corporation Information
12.5.2 CAHIC Description and Business Overview
12.5.3 CAHIC Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 CAHIC Veterinary Vaccine Products Offered
12.5.5 CAHIC Recent Development
12.6 HVRI
12.6.1 HVRI Corporation Information
12.6.2 HVRI Description and Business Overview
12.6.3 HVRI Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 HVRI Veterinary Vaccine Products Offered
12.6.5 HVRI Recent Development
12.7 Ringpu Biology
12.7.1 Ringpu Biology Corporation Information
12.7.2 Ringpu Biology Description and Business Overview
12.7.3 Ringpu Biology Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Ringpu Biology Veterinary Vaccine Products Offered
12.7.5 Ringpu Biology Recent Development
12.8 Yebio
12.8.1 Yebio Corporation Information
12.8.2 Yebio Description and Business Overview
12.8.3 Yebio Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Yebio Veterinary Vaccine Products Offered
12.8.5 Yebio Recent Development
12.9 DHN
12.9.1 DHN Corporation Information
12.9.2 DHN Description and Business Overview
12.9.3 DHN Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 DHN Veterinary Vaccine Products Offered
12.9.5 DHN Recent Development
12.10 WINSUN
12.10.1 WINSUN Corporation Information
12.10.2 WINSUN Description and Business Overview
12.10.3 WINSUN Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 WINSUN Veterinary Vaccine Products Offered
12.10.5 WINSUN Recent Development
12.11 Merck
12.11.1 Merck Corporation Information
12.11.2 Merck Description and Business Overview
12.11.3 Merck Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Merck Veterinary Vaccine Products Offered
12.11.5 Merck Recent Development
12.12 Virbac
12.12.1 Virbac Corporation Information
12.12.2 Virbac Description and Business Overview
12.12.3 Virbac Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Virbac Products Offered
12.12.5 Virbac Recent Development
12.13 Jinyu Bio-Technology
12.13.1 Jinyu Bio-Technology Corporation Information
12.13.2 Jinyu Bio-Technology Description and Business Overview
12.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Jinyu Bio-Technology Products Offered
12.13.5 Jinyu Bio-Technology Recent Development
12.14 ChengDu Tecbond
12.14.1 ChengDu Tecbond Corporation Information
12.14.2 ChengDu Tecbond Description and Business Overview
12.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.14.4 ChengDu Tecbond Products Offered
12.14.5 ChengDu Tecbond Recent Development
12.15 CAVAC
12.15.1 CAVAC Corporation Information
12.15.2 CAVAC Description and Business Overview
12.15.3 CAVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.15.4 CAVAC Products Offered
12.15.5 CAVAC Recent Development
12.16 Kyoto Biken Laboratories
12.16.1 Kyoto Biken Laboratories Corporation Information
12.16.2 Kyoto Biken Laboratories Description and Business Overview
12.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Kyoto Biken Laboratories Products Offered
12.16.5 Kyoto Biken Laboratories Recent Development
12.17 FATRO
12.17.1 FATRO Corporation Information
12.17.2 FATRO Description and Business Overview
12.17.3 FATRO Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.17.4 FATRO Products Offered
12.17.5 FATRO Recent Development
12.18 Vaksindo
12.18.1 Vaksindo Corporation Information
12.18.2 Vaksindo Description and Business Overview
12.18.3 Vaksindo Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Vaksindo Products Offered
12.18.5 Vaksindo Recent Development
12.19 Bio-Labs
12.19.1 Bio-Labs Corporation Information
12.19.2 Bio-Labs Description and Business Overview
12.19.3 Bio-Labs Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Bio-Labs Products Offered
12.19.5 Bio-Labs Recent Development
12.20 Avimex Animal Health
12.20.1 Avimex Animal Health Corporation Information
12.20.2 Avimex Animal Health Description and Business Overview
12.20.3 Avimex Animal Health Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Avimex Animal Health Products Offered
12.20.5 Avimex Animal Health Recent Development
12.21 MEVAC
12.21.1 MEVAC Corporation Information
12.21.2 MEVAC Description and Business Overview
12.21.3 MEVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.21.4 MEVAC Products Offered
12.21.5 MEVAC Recent Development
12.22 Biovac
12.22.1 Biovac Corporation Information
12.22.2 Biovac Description and Business Overview
12.22.3 Biovac Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Biovac Products Offered
12.22.5 Biovac Recent Development
12.23 Atafen
12.23.1 Atafen Corporation Information
12.23.2 Atafen Description and Business Overview
12.23.3 Atafen Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.23.4 Atafen Products Offered
12.23.5 Atafen Recent Development
12.24 Dyntec
12.24.1 Dyntec Corporation Information
12.24.2 Dyntec Description and Business Overview
12.24.3 Dyntec Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.24.4 Dyntec Products Offered
12.24.5 Dyntec Recent Development
12.25 BioTestLab
12.25.1 BioTestLab Corporation Information
12.25.2 BioTestLab Description and Business Overview
12.25.3 BioTestLab Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.25.4 BioTestLab Products Offered
12.25.5 BioTestLab Recent Development
12.26 RVSRI
12.26.1 RVSRI Corporation Information
12.26.2 RVSRI Description and Business Overview
12.26.3 RVSRI Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.26.4 RVSRI Products Offered
12.26.5 RVSRI Recent Development
12.27 Medion
12.27.1 Medion Corporation Information
12.27.2 Medion Description and Business Overview
12.27.3 Medion Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.27.4 Medion Products Offered
12.27.5 Medion Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Veterinary Vaccine Industry Trends
13.2 Veterinary Vaccine Market Drivers
13.3 Veterinary Vaccine Market Challenges
13.4 Veterinary Vaccine Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Veterinary Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Veterinary Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Live Attenuated Vaccines
Table 3. Major Manufacturers of Inactivated Vaccines
Table 4. Major Manufacturers of Others
Table 5. Global Veterinary Vaccine Market Size Growth Rate by Application (2021-2027) & (M Doses)
Table 6. Global Veterinary Vaccine Market Size by Region (M Doses) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Veterinary Vaccine Sales by Regions (2016-2021) & (M Doses)
Table 8. Global Veterinary Vaccine Sales Market Share by Regions (2016-2021)
Table 9. Global Veterinary Vaccine Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Veterinary Vaccine Sales Forecast by Region (2022-2027) & (M Doses)
Table 11. Global Veterinary Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Veterinary Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Veterinary Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Veterinary Vaccine Sales by Manufacturers (2016-2021) (M Doses)
Table 15. Global Veterinary Vaccine Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Veterinary Vaccine Manufacturers by Revenue (US$ Million) in 2020
Table 17. Veterinary Vaccine Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Veterinary Vaccine Revenue Share by Manufacturers (2016-2021)
Table 19. Global Veterinary Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Veterinary Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Vaccine as of 2020)
Table 21. Key Manufacturers Veterinary Vaccine Price (2016-2021) (USD/Doses)
Table 22. Veterinary Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Veterinary Vaccine Product Type
Table 24. Date of International Manufacturers Enter into Veterinary Vaccine Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Veterinary Vaccine Sales by Type (2016-2021) (M Doses)
Table 27. Global Veterinary Vaccine Sales Share by Type (2016-2021)
Table 28. Global Veterinary Vaccine Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Veterinary Vaccine Revenue Share by Type (2016-2021)
Table 30. Veterinary Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/Doses)
Table 31. Global Veterinary Vaccine Sales Forecast by Type (2022-2027) & (M Doses)
Table 32. Global Veterinary Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Veterinary Vaccine Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Veterinary Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Veterinary Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Doses)
Table 36. Global Veterinary Vaccine Sales by Application (2016-2021) (M Doses)
Table 37. Global Veterinary Vaccine Sales Share by Application (2016-2021)
Table 38. Global Veterinary Vaccine Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Veterinary Vaccine Revenue Share by Application (2016-2021)
Table 40. Veterinary Vaccine Average Selling Price (ASP) by Application (2016-2021) & (USD/Doses)
Table 41. Global Veterinary Vaccine Sales Forecast by Application (2022-2027) & (M Doses)
Table 42. Global Veterinary Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Veterinary Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Veterinary Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Veterinary Vaccine Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Doses)
Table 46. China Veterinary Vaccine Sales (M Doses) of Key Companies (2016-2021)
Table 47. China Veterinary Vaccine Sales Share by Company (2016-2021)
Table 48. China Veterinary Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 49. China Veterinary Vaccine Revenue Share by Company (2016-2021)
Table 50. China Veterinary Vaccine Sales (M Doses) by Type (2016-2021)
Table 51. China Veterinary Vaccine Sales Share by Type (2016-2021)
Table 52. China Veterinary Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China Veterinary Vaccine Price (USD/Doses) by Type (2016-2021)
Table 54. China Veterinary Vaccine Sales (M Doses) by Type (2022-2027)
Table 55. China Veterinary Vaccine Sales Share by Type (2022-2027)
Table 56. China Veterinary Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China Veterinary Vaccine Revenue Share by Type (2022-2027)
Table 58. China Veterinary Vaccine Price (USD/Doses) by Type (2022-2027)
Table 59. China Veterinary Vaccine Sales (M Doses) by Application (2016-2021)
Table 60. China Veterinary Vaccine Sales Share by Application (2016-2021)
Table 61. China Veterinary Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China Veterinary Vaccine Price (USD/Doses) by Application (2016-2021)
Table 63. China Veterinary Vaccine Sales (M Doses) by Application (2022-2027)
Table 64. China Veterinary Vaccine Sales Share by Application (2022-2027)
Table 65. China Veterinary Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China Veterinary Vaccine Revenue Share by Application (2022-2027)
Table 67. China Veterinary Vaccine Price (USD/Doses) by Application (2022-2027)
Table 68. North America Veterinary Vaccine Sales by Country (2016-2021) & (M Doses)
Table 69. North America Veterinary Vaccine Sales Market Share by Country (2016-2021)
Table 70. North America Veterinary Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Veterinary Vaccine Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Veterinary Vaccine Sales by Region (2016-2021) & (M Doses)
Table 73. Asia Pacific Veterinary Vaccine Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Veterinary Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Veterinary Vaccine Revenue Market Share by Region (2016-2021)
Table 76. Europe Veterinary Vaccine Sales by Country (2016-2021) & (M Doses)
Table 77. Europe Veterinary Vaccine Sales Market Share by Country (2016-2021)
Table 78. Europe Veterinary Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Veterinary Vaccine Revenue Market Share by Country (2016-2021)
Table 80. Latin America Veterinary Vaccine Sales by Country (2016-2021) & (M Doses)
Table 81. Latin America Veterinary Vaccine Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Veterinary Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Veterinary Vaccine Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Veterinary Vaccine Sales by Country (2016-2021) & (M Doses)
Table 85. Middle East and Africa Veterinary Vaccine Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Veterinary Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Veterinary Vaccine Revenue Market Share by Country (2016-2021)
Table 88. Merck Corporation Information
Table 89. Merck Description and Business Overview
Table 90. Merck Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 91. Merck Veterinary Vaccine Product
Table 92. Merck Recent Development
Table 93. Zoetis Corporation Information
Table 94. Zoetis Description and Business Overview
Table 95. Zoetis Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 96. Zoetis Product
Table 97. Zoetis Recent Development
Table 98. Boehringer Ingelheim Corporation Information
Table 99. Boehringer Ingelheim Description and Business Overview
Table 100. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 101. Boehringer Ingelheim Product
Table 102. Boehringer Ingelheim Recent Development
Table 103. Ceva Corporation Information
Table 104. Ceva Description and Business Overview
Table 105. Ceva Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 106. Ceva Product
Table 107. Ceva Recent Development
Table 108. CAHIC Corporation Information
Table 109. CAHIC Description and Business Overview
Table 110. CAHIC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 111. CAHIC Product
Table 112. CAHIC Recent Development
Table 113. HVRI Corporation Information
Table 114. HVRI Description and Business Overview
Table 115. HVRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 116. HVRI Product
Table 117. HVRI Recent Development
Table 118. Ringpu Biology Corporation Information
Table 119. Ringpu Biology Description and Business Overview
Table 120. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 121. Ringpu Biology Product
Table 122. Ringpu Biology Recent Development
Table 123. Yebio Corporation Information
Table 124. Yebio Description and Business Overview
Table 125. Yebio Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 126. Yebio Product
Table 127. Yebio Recent Development
Table 128. DHN Corporation Information
Table 129. DHN Description and Business Overview
Table 130. DHN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 131. DHN Product
Table 132. DHN Recent Development
Table 133. WINSUN Corporation Information
Table 134. WINSUN Description and Business Overview
Table 135. WINSUN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 136. WINSUN Product
Table 137. WINSUN Recent Development
Table 138. Elanco Corporation Information
Table 139. Elanco Description and Business Overview
Table 140. Elanco Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 141. Elanco Product
Table 142. Elanco Recent Development
Table 143. Virbac Corporation Information
Table 144. Virbac Description and Business Overview
Table 145. Virbac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 146. Virbac Product
Table 147. Virbac Recent Development
Table 148. Jinyu Bio-Technology Corporation Information
Table 149. Jinyu Bio-Technology Description and Business Overview
Table 150. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 151. Jinyu Bio-Technology Product
Table 152. Jinyu Bio-Technology Recent Development
Table 153. ChengDu Tecbond Corporation Information
Table 154. ChengDu Tecbond Description and Business Overview
Table 155. ChengDu Tecbond Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 156. ChengDu Tecbond Product
Table 157. ChengDu Tecbond Recent Development
Table 158. CAVAC Corporation Information
Table 159. CAVAC Description and Business Overview
Table 160. CAVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 161. CAVAC Product
Table 162. CAVAC Recent Development
Table 163. Kyoto Biken Laboratories Corporation Information
Table 164. Kyoto Biken Laboratories Description and Business Overview
Table 165. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 166. Kyoto Biken Laboratories Product
Table 167. Kyoto Biken Laboratories Recent Development
Table 168. FATRO Corporation Information
Table 169. FATRO Description and Business Overview
Table 170. FATRO Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 171. FATRO Product
Table 172. FATRO Recent Development
Table 173. Vaksindo Corporation Information
Table 174. Vaksindo Description and Business Overview
Table 175. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 176. Vaksindo Product
Table 177. Vaksindo Recent Development
Table 178. Bio-Labs Corporation Information
Table 179. Bio-Labs Description and Business Overview
Table 180. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 181. Bio-Labs Product
Table 182. Bio-Labs Recent Development
Table 183. Avimex Animal Health Corporation Information
Table 184. Avimex Animal Health Description and Business Overview
Table 185. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 186. Avimex Animal Health Product
Table 187. Avimex Animal Health Recent Development
Table 188. MEVAC Corporation Information
Table 189. MEVAC Description and Business Overview
Table 190. MEVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 191. MEVAC Product
Table 192. MEVAC Recent Development
Table 193. Biovac Corporation Information
Table 194. Biovac Description and Business Overview
Table 195. Biovac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 196. Biovac Product
Table 197. Biovac Recent Development
Table 198. Atafen Corporation Information
Table 199. Atafen Description and Business Overview
Table 200. Atafen Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 201. Atafen Product
Table 202. Atafen Recent Development
Table 203. Dyntec Corporation Information
Table 204. Dyntec Description and Business Overview
Table 205. Dyntec Veterinary Vaccine Sales (M Doses), Revenue (US$ Millio

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Classical Swine Fever Vaccines Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 100

It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......

Global Tylosin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......

Global Animal Parasiticides Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......

Global Newcastle Disease Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114

According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......

Global Classical Swine Fever Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 126

According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period. The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......

Global Veterinary Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151

According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period. The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......

Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......

Global Veterinary Products for Companion Animals Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......

Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 115

According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period. Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs